Aurobindo Pharma USA, Inc. · 4 months ago
Scientist II, Inhalation Research and Development-NC
Durham, North Carolina
Full-time
Onsite
Mid Level
$70K/yr - $80K/yr
4+ years expAurobindo Pharma USA, Inc. is a global pharmaceutical company focused on delivering a broad portfolio of quality, affordable generic pharmaceuticals. The Scientist II in Inhalation Research and Development will perform characterization studies for inhalation products, particularly metered dose inhalers (MDIs), and will be responsible for developing and validating test methods as per FDA and ICH guidelines.
BiotechnologyPharmaceutical
Responsibilities
Will perform inhalation testing for inhalation products, particularly MDIs
Will be proficient in MDI characterization methods including total can assay, aerodynamic particle size by cascade impaction, delivered dose through container life, Karl Fischer, spray pattern& plume geometry, foreign particulate matter, and microscopic evaluation
Will work with analytical scientists to support their development of assay and impurities methods and for routine testing
Capable of troubleshooting methods
Prepares SOPs, protocols, and reports
Meets timelines
Performs studies according to the stage-appropriate quality system
Qualification
Required
Proficient in developing, validating, and executing MDI characterization methods
Must be able to perform laboratories duties that require standing for up to 90% of the work day, lifting containers containing 4+L of liquids and fine motor skills for conducting laboratory experiments (including weighing and pipetting)
BS in Chemistry, Pharmaceutical Sciences, Chemical Engineering, or related scientific field with 6+ years' experience or MS with 4+ years' experience
At least one year of experience in MDI product development
Preferred
cGMP pharmaceutical experience
Company
Aurobindo Pharma USA, Inc.
Aurobindo Pharma is a pharmaceuticals company offering generic pharmaceuticals.
501-1000 employees
H1B Sponsorship
Aurobindo Pharma USA, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (4)
2023 (4)
2022 (10)
2021 (9)
2020 (10)
Funding
Current Stage
Late StageLeadership Team
Swami Sambamurty Iyer
Chief Executive Officer
Recent News
2025-06-28
Business Standard India
2024-11-25
2024-11-24
Company data provided by crunchbase